Psychotropic Auto-Tagging Rules ensures all applicable Routine and PRN psychotropic medication orders are automatically tagged as a Psychotropic Drug when processing new orders in the Pharmacy Inbox or manually creating orders on the Manage Orders page.
ALIS automatically tags controlled substances with the "Controlled" Medication Tag, however your state may also require you to have the specific "Psychotropic Drug" identifier visible on applicable medication orders.
Our drug database does not track if a drug is psychotropic because there is not a national standard or single list of psychotropic drugs, and each state's classifications vary. Therefore, setting the auto-tagging rules in ALIS allows you to customize this list of psychotropic medications per your state needs.
Settings
As long as your ALIS environment is linked to our drug database, you will be able to manage your community's list of psychotropic medications to auto-tag in Medications Settings.
If you need the Drug Database entitlement enabled, contact your Account Manager or our ALIS Customer Success Team.
Add a Psychotropic Tag Rule
You have the option to add or remove drugs from the list to customize which medications are considered psychotropic based on your licensure.
- To Add a Psychotropic Tag Rule, navigate to Settings > Medications and click on the Psychotropic Tagging tab.
- In the Psychotropic Tagging tab, click +Add.
-
Then, search our Drug Database for the drug name or category by typing a GPI Segment or specific drug name in the Search Drug Name field.
- Select all applicable drug names and categories from the list of Drug Category Descriptions. The guide, Psychotropic Auto-Tagging: GPI Index, can serve as a reference for GPI Segments and Drug Category Descriptions. Once you've made your selections, click Submit to save your choices.
Tip: Use the "GPI Match Count" column as a guide when selecting applicable drug categories. This column shows the number of GPI matches for residents' active medication orders currently in ALIS.
Remove a Psychotropic Tag Rule
To remove a Psychotropic Tag Rule from the list, identify the drug category description, and click Delete.
Copy Settings
Easily copy your configured Psychotropic Tagging Rules settings to other communities in your portfolio.
Click Copy To, and then choose the communities from the list in which you want to apply these settings. Click Save to copy!
Incoming Orders
Once your Psychotropic Tag Rules have been configured in Settings, any new manually created or pharmacy linked orders under the same drug category will be automatically tagged as "Psychotropic Drug."
These Psychotropic Tag Rules tag rules will apply even when set after an order has already been created or processed. This means that if any psychotropic medication on your list was not previously tagged as such on a resident's eMAR, applicable psychotropic medications will be tagged retroactively.
When processing an order in the Pharmacy Inbox, ALIS will automatically tag an order as a Psychotropic Drug if it is one found on your Psychotropic Tag Rules list.
Manually Created Orders
Psychotropic Auto-Tagging Rules also apply to any new manually created orders.
When you go to manually create an order in the Manage Orders page and click +Add Routine or +Add PRN, you will see the auto-tag occur once you type in the medication name and dosage.
Medication List Report
Utilizing auto-tagging feature facilitates strong reporting on residents currently taking psychotropic medications in your community at any given time.
View any residents currently taking psychotropic medications in your community by filtering the Medication List Report for the Psychotropic Drug Tag.
-
Go to Reports > Medication List report.
- Click on the Medication Tags dropdown to select the type of medication(s) from the list to filter the report. Set the Date Range and other filters as desired, then click Refresh to view your data set.
To learn more about how and why you might use Medication Tags, refer to this Custom Med Tags guide.
Related Articles:
Comments
0 comments
Article is closed for comments.